Interim Analysis
Approaches to interim analysis of cancer randomised clinical trials with time to event endpoints: A survey from the Italian National Monitoring Centre for Clinical Trials
6
An internal pilot study with interim analysis for Gaussian linear models
161
A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials
16
Real world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6 month interim analysis of the 2 year, observational, prospective ACTION study
13
ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing’s syndrome
12
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs
9
Prevention of abdominal wound infection (PROUD trial, DRKS00000390): study protocol for a randomized controlled trial
10
A multi stage drop the losers design for multi arm clinical trials
18
Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)
8
Effects of Intracoronary Administration of Autologous Adipose Tissue Derived Stem Cells on Acute Myocardial Infarction in a Porcine Model
8
The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias
8
A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines
10
An adaptive two arm clinical trial using early endpoints to inform decision making: design for a study of sub acromial spacers for repair of rotator cuff tendon tears
14
Predicting clinical trial results based on announcements of interim analyses
8
Real world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study
11
Sequential sample size re estimation in clinical trials with multiple co primary endpoints
332
Targeted alpha anticancer therapies: update and future prospects
13
Interim analyses of data as they accumulate in laboratory experimentation
6
Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis
9
Retrieval of convective available potential energy from INSAT-3D measurements: comparison with radiosonde data and their spatial–temporal variations
14